Middle East & Africa In Vitro Diagnostics Market

This study involved the extensive use of primary and secondary sources. A comprehensive study was conducted using secondary research methods to gather data about the market, its parent market, and its peer markets. The next stage involved conducting primary research to confirm these conclusions and assumptions and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. The market sizes of segments and subsegments were then estimated using data triangulation techniques and market breakdown.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), American Association for Clinical Chemistry (AACC), American Diabetes Association (ADA), Association for Molecular Pathology (AMP) and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the Middle East & Africa In Vitro Diagnostics Market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the Middle East & Africa In Vitro Diagnostics Market. The primary sources from the demand side include hospitals & clinics, clinical laboratories, blood banks, pharmaceutical and biotechnology companies, and academic institutes. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

Market Size Estimation

For the market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the Middle East & Africa In Vitro Diagnostics Market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. The Middle East & Africa In Vitro Diagnostics Market was split into various segments and sub-segments based on:

• List of major players operating in the products market at the regional and/or country level.
• Product mapping of various in vitro diagnostics manufacturers at the regional and/or country level.
• Mapping of annual revenue generated by listed major players from in vitro diagnostics (or the nearest reported business unit/product category).
• Extrapolation of the revenue mapping of the listed major players to derive the market value of the respective segments/subsegments.
• Summation of the market value of all segments/subsegments to arrive at the Middle East & Africa In Vitro Diagnostics Market.

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Data Triangulation

After arriving at the overall size of the Middle East & Africa In Vitro Diagnostics Market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. Examining several macro variables and regional trends from demand- and supply-side players helped triangulate the extrapolated market data.

Market Definition

IVD tests are non-invasive tests performed to diagnose, monitor, screen, and assess diseases and health conditions. The term "in vitro," which refers to "in glass," signifies that test tubes or petri dishes are typically used in these tests. These tests are performed artificially on biological samples (blood, urine, and tissues). IVD has a broad scope ranging from sophisticated technologies performed in clinical laboratories to simple and easy-to-use rapid testing kits.

IVD is used to assess a person's health. This technique is used in precision medicine to determine the suitable course of treatment for particular patients and diagnose and prevent diseases and other medical disorders.

Stakeholders

• Transfection products manufacturing companies
• Pharmaceutical & Biopharmaceutical Companies
• Chemical Companies
• Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Contract Development and Manufacturing Organizations (CDMOs)
• Research Institutes and Universities 
• Venture Capitalists & Investors
• Government Associations

Report Objectives

• To define, describe, and forecast the in vitro diagnostics (IVD) market based on product & service, technology, specimen, site of testing, application, end user, and region.
• To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and industry-specific challenges).
• To assess the Middle East & Africa In Vitro Diagnostics Market with respect to Porter’s Five Forces, regulatory landscape, the value chain, the supply chain, ecosystem analysis, patent protection, pricing assessment, key stakeholders, and buying criteria.
• To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.
• To analyze the opportunities in the IVD market for stakeholders and provide details of the competitive landscape for market leaders.
• To profile the key players operating in the IVD market and comprehensively analyze their core competencies and market shares.
• To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, expansions, product/technology developments, and product approvals.
• To benchmark players within the IVD market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within categories of business strategies, market share, and product offerings.